Eastman Chemical (NYSE:EMN - Get Free Report) updated its FY 2025 earnings guidance on Thursday. The company provided earnings per share (EPS) guidance of 8.000-8.750 for the period, compared to the consensus estimate of 8.460. The company issued revenue guidance of -.
NYSE EMN traded down $0.08 during trading hours on Thursday, reaching $92.62. 1,379,102 shares of the company were exchanged, compared to its average volume of 1,043,472. The company has a quick ratio of 0.78, a current ratio of 1.52 and a debt-to-equity ratio of 0.80. The stock has a market capitalization of $10.74 billion, a P/E ratio of 12.40, a P/E/G ratio of 0.67 and a beta of 1.44. Eastman Chemical has a 1 year low of $80.71 and a 1 year high of $114.50. The business's 50 day simple moving average is $95.14 and its 200-day simple moving average is $100.07.
Eastman Chemical (NYSE:EMN - Get Free Report) last released its earnings results on Thursday, January 30th. The basic materials company reported $1.87 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.60 by $0.27. Eastman Chemical had a return on equity of 15.37% and a net margin of 9.47%. On average, equities research analysts expect that Eastman Chemical will post 7.6 earnings per share for the current year.
The business also recently declared a quarterly dividend, which was paid on Wednesday, January 8th. Stockholders of record on Monday, December 16th were given a $0.83 dividend. The ex-dividend date of this dividend was Monday, December 16th. This is a boost from Eastman Chemical's previous quarterly dividend of $0.81. This represents a $3.32 annualized dividend and a dividend yield of 3.58%. Eastman Chemical's payout ratio is 44.44%.
A number of research firms have weighed in on EMN. Citigroup lowered Eastman Chemical from a "buy" rating to a "neutral" rating and reduced their target price for the company from $118.00 to $104.00 in a report on Wednesday, December 18th. Wells Fargo & Company raised shares of Eastman Chemical from an "equal weight" rating to an "overweight" rating and upped their target price for the stock from $110.00 to $125.00 in a report on Tuesday, November 26th. Piper Sandler cut their price target on shares of Eastman Chemical from $105.00 to $102.00 and set a "neutral" rating for the company in a report on Tuesday, January 7th. StockNews.com upgraded Eastman Chemical from a "hold" rating to a "buy" rating in a research report on Saturday, January 18th. Finally, Mizuho boosted their target price on Eastman Chemical from $113.00 to $117.00 and gave the stock a "neutral" rating in a research report on Tuesday, November 26th. Six analysts have rated the stock with a hold rating and eight have issued a buy rating to the stock. Based on data from MarketBeat, the stock currently has a consensus rating of "Moderate Buy" and an average price target of $112.92.
Check Out Our Latest Report on Eastman Chemical
In related news, SVP Julie A. Mcalindon sold 4,456 shares of the firm's stock in a transaction dated Tuesday, November 26th. The stock was sold at an average price of $105.84, for a total value of $471,623.04. Following the sale, the senior vice president now directly owns 4,403 shares of the company's stock, valued at $466,013.52. This trade represents a 50.30 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, SVP Christopher Moore Killian sold 3,061 shares of the stock in a transaction that occurred on Wednesday, November 6th. The stock was sold at an average price of $105.00, for a total value of $321,405.00. Following the completion of the sale, the senior vice president now owns 12,366 shares of the company's stock, valued at approximately $1,298,430. This trade represents a 19.84 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 18,021 shares of company stock worth $1,895,948 in the last ninety days. 1.93% of the stock is owned by insiders.
Eastman Chemical Company operates as a specialty materials company in the United States, China, and internationally. The company's Additives & Functional Products segment offers amine derivative-based building blocks, intermediates for surfactants, metam-based soil fumigants, and organic acid-based solutions; specialty coalescent and solvents, paint additives, and specialty polymers; and heat transfer and aviation fluids.
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to [email protected].
Before you consider Eastman Chemical, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Eastman Chemical wasn't on the list.
While Eastman Chemical currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.